Analystreport

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) had its price target raised by analysts at Piper Sandler from $36.00 to $42.00.

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com